Aridis Pharmaceuticals, Inc.
ARDS
Revenue
417.00k
▼-19.23M▼-97.88%
3 Months ChangeAssets
6.53M
▲52.00k▲0.8022%
3 Months ChangeLiabilities
18.34M
▼-3.06M▼-14.30%
3 Months ChangeFree Cash Flow
-10.19M
▼-5.85M▼-134.62%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-06-27
Form 8-K
ID: 0001493152-24-025437
2024-01-16
Form 8-K
ID: 0001493152-24-002304
2023-12-18
Form 8-K
ID: 0001493152-23-045212
2023-11-06
Form 10-Q
ID: 0001493152-23-039521
2023-11-03
Form 8-K
ID: 0001493152-23-039349
2023-09-14
Form 10-Q
ID: 0001493152-23-032540
2023-09-07
Form 8-K
ID: 0001493152-23-031977
2023-08-25
Form 8-K
ID: 0001493152-23-030213
2023-08-09
Form 8-K
ID: 0001493152-23-027356
2023-07-20
Form 8-K
ID: 0001493152-23-025128